Registry for patients with BCR-ABL1-negative myeloid neoplasms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect data from a large cohort of patients diagnosed with BCR-ABL1-negative myeloid neoplasms, following the WHO classification. It involves the storage of various biological samples, including bone marrow and blood, for future morphologic and genetic analyses. The study will assess clinical characteristics, outcomes, and quality of life, while also correlating biological features with clinical data to identify prognostic and predictive markers. This observational approach will enhance understanding of the disease and its impact on patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Both female and male patients meeting the mentioned inclusion criteria will be included in this registry, because the risk to get a myeloid neoplasm does not depend on a patient's gender. Patients must meet all of the following inclusion criteria to be eligible for enrollment into the registry:

* Patients with BCR-ABL 1-myeloid neoplasia according to WHO classification or IWG MRI criteria
* Age ≥ 18 years. There is no upper age limit.
* Signed written informed consent.

Exclusion Criteria:

* Severe neurological or psychiatric disorder interfering with ability to give an informed consent
* No consent for registration, storage and handling of the personal data

Where it's running

• Hämatologische Onkologie Praxis Augsburg
  Augsburg, Germany Recruiting
• Klinikum Augsburg
  Augsburg, Germany Recruiting
• Helios Klinikum, Bad Saarow
  Bad Saarow, Germany Recruiting
• Klinikum Mittelbaden
  Baden-Baden, Germany Recruiting
• MVZ Klinikum Coburg
  Coburg, Germany Recruiting
• Donauwörth, Onko-Medeor
  Donauwörth, Germany Recruiting

Study contacts

• Study coordinator: Frank Stegelmann, Dr.
• Email: frank.stegelmann@uniklinik-ulm.de
• Phone: +4973150045521

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Glucose levels during a 6 km loaded march

  We will test how blood sugar changes during a 6 km march carrying 15 kg of equipment in healthy soldiers using continuous glucose monitors.

  Recruiting University of Ulm · Ulm · NCT07543705

• Parental metabolism's imprint on the fetal epigenome in gestational diabetes

  We will see if parents' metabolism during pregnancy is linked to epigenetic changes in the fetus in pregnancies with and without gestational diabetes.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07436195

• How changing thyroid hormone levels affects blood sugar, lipids, and energy use

  This trial will test whether raising or lowering thyroid hormones in people with newly diagnosed Graves' disease or thyroid cancer changes blood sugar, insulin, and lipid metabolism using oral glucose tolerance tests.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07410637

• Once-weekly semaglutide for weight loss in adolescents with monogenic obesity

  This study tests whether once-weekly semaglutide 2.4 mg together with a reduced-calorie diet and increased activity helps adolescents with monogenic obesity lose weight, reduce hunger, and improve quality of life over 68 weeks.

  Recruiting University of Ulm · Paris and 6 other locations · NCT07302802

• Global registry for genetic obesity

  This registry collects health and genetic information from people with genetically confirmed or early-onset severe obesity to see if different genes relate to symptoms, complications, and treatment responses.

  Recruiting University of Ulm · Ulm · NCT07296900

• Immunoadsorption treatment for chronic inflammatory demyelinating polyneuropathy

  This observational study will try immunoadsorption as a next-step treatment for adults with CIDP who do not respond well to IVIg or methylprednisolone.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07154524

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.